Corporate Announcement
Security Code : 507789    Company : JAGSNPHARM    
 
Jagsonpal Pharmaceuticals - Outcome of AGM 
  Exchange Disseminated Time     
Jagsonpal Pharmaceuticals Ltd has informed BSE that the shareholders/members at the Annual General Meeting (AGM) of the Company held on September 30, 2009, inter alia, have accorded to the following:

1. Adopted the Audited Balance Sheet as at March 31, 2009 and the Profit and loss account for the Year ended on that date alongwith the reports of the Auditors and Directors thereon.

2. Declared 5% dividend in the Equity Shares.

3. Re-appointed Mr. A. C. Chakrabortti as Director whose period of office is liable to determination by retirement of Directors by rotation.

4. Appointed P. P. Thukral & Company, Chartered Accountants as Auditor hold office till the conclusion of next Annual General Meeting.
 

Disclaimer

Back To Announcements